These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6727282)

  • 1. [Temperature-dependent spontaneous platelet aggregation in polycythemia vera and primary thrombocythemia: a diagnostic criterion].
    Fröhli P; Streuli R; Rhyner K
    Klin Wochenschr; 1984 May; 62(9):412-6. PubMed ID: 6727282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet function in patients with high platelet counts.
    Ginsburg AD
    Ann Intern Med; 1975 Apr; 82(4):506-11. PubMed ID: 1054537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating erythroid and megakaryocytic progenitors in polycythaemia vera and essential thrombocythaemia.
    Florensa L; Besses C; Almarcha J; Lafuente R; Palou L; Pedro C; Sans-Sabrafen J; Woessner S
    Eur J Haematol; 1989 Nov; 43(5):417-22. PubMed ID: 2693129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hitherto undescribed defect of platelet coagulant activity in polycythaemia vera and essential thrombocythaemia.
    Semeraro N; Cortellazzo S; Colucci M; Barbui T
    Thromb Res; 1979; 16(5-6):795-802. PubMed ID: 524321
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced platelet factor X-activating activity: a possible contribution to bleeding complications in polycythaemia vera and essential thrombocythaemia.
    Cortellazzo S; Colucci M; Barbui T; Dini E; Semeraro N
    Haemostasis; 1981; 10(1):37-50. PubMed ID: 7203175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
    Barbui T; Battista R; Dini E
    Acta Haematol; 1973; 50(1):25-9. PubMed ID: 4200801
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristic changes in platelet-large cell ratio, lactate dehydrogenase and C-reactive protein in thrombocytosis-related diseases.
    Kabutomori O; Kanakura Y; Iwatani Y
    Acta Haematol; 2007; 118(2):84-7. PubMed ID: 17622783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of beta-thromboglobulin in patients with high platelet count.
    Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Bonvicini P; Girolami A
    Acta Haematol; 1984; 71(1):32-8. PubMed ID: 6197855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytosis, thrombocythaemia and iron deficiency in patients with polycythaemia vera.
    Shaw D; Tudhope GR
    Acta Haematol; 1979; 62(4):223-8. PubMed ID: 119415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative platelet defect and thrombohaemorrhagic complications in a patient with polycythaemia vera. Case 10.
    Friess D; Lämmle B; Alberio L
    Hamostaseologie; 2003 Aug; 23(3):138-43. PubMed ID: 12923585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.
    Ruggeri M; Tosetto A; Frezzato M; Rodeghiero F
    Ann Intern Med; 2003 Sep; 139(6):470-5. PubMed ID: 13679323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin levels in patients with primary and reactive thrombocytosis.
    Cerutti A; Custodi P; Duranti M; Noris P; Balduini CL
    Br J Haematol; 1997 Nov; 99(2):281-4. PubMed ID: 9375739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of beta-thromboglobulin and platelet factor-4 in polycythaemic patients.
    Najean Y; Poirier O; Lokiec F
    Scand J Haematol; 1983 Oct; 31(4):298-304. PubMed ID: 6194555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet malonyldialdehyde and spontaneous aggregation during ischaemic attacks of patients with polycythaemia vera.
    Cortelazzo S; Barbui T; Viero P; Bassan R; Dini E; Ferro Milone F
    Thromb Haemost; 1979 Dec; 42(4):1344-6. PubMed ID: 542939
    [No Abstract]   [Full Text] [Related]  

  • 15. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
    Murphy S; Davis JL; Walsh PN; Gardner FH
    Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia.
    Squizzato A; Romualdi E; Middeldorp S
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006503. PubMed ID: 18425953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of the control of antiplatelet therapy through platelet aggregation rate on polycythemia vera associated with thrombocytosis and erythromelalgia].
    Kurihara A; Kobayashi I; Tamura K
    Rinsho Ketsueki; 1989 Jan; 30(1):99-104. PubMed ID: 2716205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders.
    Balduini CL; Bertolino G; Noris P; Piletta GC
    Am J Clin Pathol; 1991 Jan; 95(1):82-6. PubMed ID: 1987755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
    Panova-Noeva M; Marchetti M; Russo L; Tartari CJ; Leuzzi A; Finazzi G; Rambaldi A; ten Cate H; Falanga A
    Thromb Res; 2013 Jul; 132(1):88-93. PubMed ID: 23735588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis.
    Fabris F; Casonato A; Grazia del Ben M; De Marco L; Girolami A
    Br J Haematol; 1986 May; 63(1):75-83. PubMed ID: 3085704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.